[
    [
        {
            "time": "2023-10-05",
            "original_text": "At US$78.27, Is It Time To Put Abbott Laboratories (NYSE:ABT) On Your Watch List?",
            "features": {
                "keywords": [
                    "Abbott Laboratories",
                    "watch list"
                ],
                "sentiment_score": 0.6,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "healthcare"
                ],
                "causal_factor": "false",
                "causal_impact": "neutral",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "At US$78.27, Is It Time To Put Abbott Laboratories (NYSE:ABT) On Your Watch List?",
                "Correlation": 9,
                "Sentiment": 6,
                "Importance": 7,
                "Impact": 6,
                "Duration": 5,
                "Entity_Density": 8,
                "Market_Scope": 3,
                "Time_Proximity": 6,
                "Headline_Structure": 8,
                "Source_Recency": 7
            }
        },
        {
            "time": "2023-10-05",
            "original_text": "CVS Health's (CVS) Q1 Earnings Top Estimates, EPS View Up",
            "features": {
                "keywords": [
                    "CVS Health",
                    "Q1 Earnings",
                    "EPS View Up"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "healthcare"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "CVS Health's (CVS) Q1 Earnings Top Estimates, EPS View Up",
                "Correlation": 10,
                "Sentiment": 9,
                "Importance": 9,
                "Impact": 8,
                "Duration": 7,
                "Entity_Density": 9,
                "Market_Scope": 4,
                "Time_Proximity": 8,
                "Headline_Structure": 7,
                "Source_Recency": 9
            }
        },
        {
            "time": "2023-10-05",
            "original_text": "Tandem's (TNDM) Q1 Loss Wider Than Expected, Sales Top Mark",
            "features": {
                "keywords": [
                    "Tandem",
                    "Q1 Loss",
                    "Sales Top Mark"
                ],
                "sentiment_score": -0.4,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "medical devices"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "Tandem's (TNDM) Q1 Loss Wider Than Expected, Sales Top Mark",
                "Correlation": 10,
                "Sentiment": 5,
                "Importance": 8,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 9,
                "Market_Scope": 3,
                "Time_Proximity": 8,
                "Headline_Structure": 8,
                "Source_Recency": 9
            }
        },
        {
            "time": "2023-10-05",
            "original_text": "IDEXX (IDXX) Q1 Earnings Top Estimates, EPS Guidance Up",
            "features": {
                "keywords": [
                    "IDEXX",
                    "Q1 Earnings",
                    "EPS Guidance Up"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "veterinary medicine"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "IDEXX (IDXX) Q1 Earnings Top Estimates, EPS Guidance Up",
                "Correlation": 10,
                "Sentiment": 9,
                "Importance": 9,
                "Impact": 8,
                "Duration": 7,
                "Entity_Density": 9,
                "Market_Scope": 3,
                "Time_Proximity": 8,
                "Headline_Structure": 7,
                "Source_Recency": 9
            }
        }
    ]
]